TBPH
Theravance Biopharma, Inc.Company with tickers: TBPH
CIK
1583107
CUSIP
G8807B106
Shares Outstanding
51,553,005
13F Activity (30d)
116 filings
113 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2020-01-08 | 2020-01-07 | |
| 8-K | 2020-01-13 | — | |
| 8-K | 2020-01-30 | 2020-01-24 | |
| 8-K | 2020-02-13 | 2020-02-10 | |
| 8-K | 2020-02-24 | — | |
| 10-K | 2020-02-27 | 2019-12-31 | |
| 8-K | 2020-03-04 | 2020-02-28 | |
| 8-K | 2020-04-09 | — | |
| 8-K | 2020-04-29 | 2020-04-28 | |
| 8-K | 2020-05-06 | — | |
| 10-Q | 2020-05-08 | 2020-03-31 | |
| 8-K | 2020-06-10 | — | |
| 8-K | 2020-06-25 | 2020-06-22 | |
| 8-K | 2020-07-06 | 2020-07-01 | |
| 8-K | 2020-08-06 | — | |
| 10-Q | 2020-08-10 | 2020-06-30 | |
| 8-K | 2020-09-14 | — | |
| 8-K | 2020-11-05 | — | |
| 10-Q | 2020-11-09 | 2020-09-30 | |
| 8-K | 2021-01-11 | — | |
| 8-K | 2021-02-23 | — | |
| 10-K | 2021-02-26 | 2020-12-31 | |
| 8-K | 2021-03-16 | 2021-03-15 | |
| 8-K | 2021-03-31 | 2021-03-30 | |
| 8-K | 2021-04-28 | 2021-04-27 | |
| 8-K | 2021-05-04 | — | |
| 10-Q | 2021-05-06 | 2021-03-31 | |
| 8-K | 2021-06-21 | — | |
| 8-K | 2021-06-28 | 2021-06-24 | |
| 8-K | 2021-08-03 | — | |
| 10-Q | 2021-08-05 | 2021-06-30 | |
| 8-K | 2021-08-23 | — | |
| 8-K | 2021-09-15 | — | |
| 8-K/A | 2021-10-05 | 2021-09-15 | |
| 8-K | 2021-11-03 | — | |
| 10-Q | 2021-11-08 | 2021-09-30 | |
| 8-K | 2021-11-16 | — | |
| 8-K/A | 2021-12-06 | 2021-09-15 | |
| 8-K | 2021-12-16 | — | |
| 8-K | 2021-12-22 | 2021-12-17 | |
| 8-K | 2022-01-10 | — | |
| 8-K | 2022-02-23 | — | |
| 10-K | 2022-02-28 | 2021-12-31 | |
| 8-K | 2022-04-04 | — | |
| 8-K | 2022-04-28 | 2022-04-26 | |
| 8-K | 2022-05-05 | — | |
| 10-Q | 2022-05-06 | 2022-03-31 | |
| 8-K | 2022-07-13 | — | |
| 8-K | 2022-07-14 | 2022-07-13 | |
| 8-K | 2022-07-20 | — |
Showing 1–50 of 118 filings